Mammakarzinom
Studientitel
Evaluation des automatisierten Brustultraschalls im Rahmen der intensivierten Früherkennung des Zentrums für Familiären Brust- und Eierstockkrebs Regensburg
Studienart
Prospektive Datenerhebung
Studientitel
Prospektive, multizentrische Registerstudie zur Bewertung verschiedener leitlinienkonformer Operationsverfahren in der Axilla (Sentinel-Node Biopsie, Targeted Axillary Dissection, Axilladissektion) nach neoadjuvanter Chemotherapie
Studienart
Prospektive Registerstudie
Studientitel
Prospective and retrospective registry study of the German Breast Group (GBG) for diagnosis and treatment of breast cancer in pregnancy compared to young non-pregnant women
Studienart
Non interventional study (NIS) / Prospektive und retrospektive Datenerhebung
Studientitel
Brain metastases in breast cancer
Studienart
Non interventional study (NIS) / Prospektive und retrospektive Datenerhebung
Studientitel
A Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative LocallyAdvanced, Unresectable or Metastatic Breast Cancer
Studienart
Interventional study / Phase III-Studie
Studientitel
Comprehensive Analysis of Spatial, Temporal and Molecular patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Studienart
Interventional study / Phase IV-Studie
Studientitel
A non-interventional study for Kisqali (Ribociclib) in combination with an aromatase inhibitor in patients with HR+/HER2- stage II and III early breast cancer to evaluate real-world effectiveness, safety profile, patient compliance and quality of life.
Studienart
Non Interventional study (NIS)
Studientitel
Comprehensive assessment of clinical features and biomarkers to identify patients with advanced or metastatic breast cancer for marker driven trials in humans
Studienart
Non interventional study (NIS) / Prospektive Registerstudie
Studientitel
Comprehensive assessment of clinical features, genomics and further molecular markers to identify patients with early breast cancer for enrolment on marker driven trials
Studienart
Non interventional study (NIS) / Prospektive Registerstudie
Studientitel
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study
Studienart
Interventional study / Phase III-Studie
Studientitel
A phase III, multicenter, randomized, double-blind, placeo-controlled study evaluating the efficacy and safety of Inavolisib plus a CDK4/6 inhibitor and Letrozole versus Placebo plus a CDK4/6 inhibitor and Letrozole in patients with endocrine-sensitive PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer.
Studienart
Interventional study / Phase III-Studie
Studientitel
Eine prospektive Registerstudie der Universitätsfrauenklinik Magdeburg in Zusammenarbeit mit der GBG (German Breast Group) zur Diagnostik und Therapie des Mammakarzinoms des Mannes
Studienart
Non interventional study (NIS) / Prospektive Registerstudie
Studientitel
MEthods for LOcalization of Different types of breast lesions: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions
Studienart
Non interventional study (NIS) / Prospektive Kohortenstudie
Studientitel
Prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/metastatic setting: health care research, pharmacogenomics, biomarkers, health economics
Studienart
Interventional study / Prospektive interventionelle Registerstudie
Studientitel
Real world data and long-term follow-up of female pre- and perimenopausal patients with luminal early breast cancer with intermediate to high clinical risk for recurrence and low genomic recurrence-risk measured by MammaPrint®, treated by standard-of-care endocrine treatment plus ovarian function suppression (OFS) or standard-of-care chemotherapy treatment followed by endocrine treatment.
Studienart
Non-Interventional study (NIS) / Prospektive offene Beobachtungsstudie
Studientitel
Prospektive nicht-interventionelle Studie (NIS) zur Untersuchung von patientenberichteten und klinischen Daten aus der Alltagsroutine bei Patienten mit HER2-positivem, HER2-low oder HER2-ultralow inoperablem oder metastasiertem Brustkrebs, die mit Trastuzumab deruxtecan behandelt werden
Studienart
Non-Interventional study (NIS)
Studientitel
SURVIVE (Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer) – a partially double-blinded, multi-center, randomized, controlled superiority study
Studienart
Interventional study / Kontrollierte, randomisierte Studie
Studientitel
Eine randomisierte kontrollierte Studie zur Bewertung der Wirksamkeit von Typologie-basiertem Coaching bei Patientinnen mit HR-Pos / HER2-neg frühen Brustkrebs im Rahmen einer adjuvanten Behandlung mit Ribociclib
Studienart
Phase IV-Studie
Studientitel
Wechselseitiger Patienten-Arzt-Austausch in der Versorgung bei Brustkrebs mit dem Ziel der gemeinsamen Erarbeitung neuer Patienten-orientierter Strukturen.
Studienart
Non-Interventional study (NIS) / non-AMG-Studie
Ovarialkarzinom
PARP inhibitor rechallenge in recurrent ovarian cancer: care reality in Bavaria, translational biomarkers, response rates and clinical outcome
Studienart
Non interventional study (NIS) / Beobachtungsstudie
Prospective non-interventional study to collect real-world clinical and patient-reported outcome data in ovarian cancer patients eligible for firstline platinum-based chemotherapy and intended for BRCA/HRD testing
Studienart
Non interventional study (NIS) / prospektive Beobachtungsstudie
Clinical research platform on ovarian, fallopian tube, primary peritoneal and endometrial cancer treatment and outcomes
Studienart
Non interventional study (NIS) / prospektive Kohortenstudie
Endometriumkarzinom
Clinical research platform on ovarian, fallopian tube, primary peritoneal and endometrial cancer treatment and outcomes
Studienart
Non interventional study (NIS) / prospektive Kohortenstudie
Kontakt
Cornelia Lämmel
Leitung Studienzentrum
E-Mail fhk-studienzentrum@csj.de
Telefon 0941 782-7512
Unsere Kooperationen am Studienzentrum der Frauenheilkunde
